BR0015693A - Oleosinas recombinantes de cacau e seu uso como agentes aromatizantes e emulsificantes - Google Patents
Oleosinas recombinantes de cacau e seu uso como agentes aromatizantes e emulsificantesInfo
- Publication number
- BR0015693A BR0015693A BR0015693-0A BR0015693A BR0015693A BR 0015693 A BR0015693 A BR 0015693A BR 0015693 A BR0015693 A BR 0015693A BR 0015693 A BR0015693 A BR 0015693A
- Authority
- BR
- Brazil
- Prior art keywords
- cocoa
- recombinant
- flavoring
- emulsifying agents
- oleosins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/86—Products or compounds obtained by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- General Preparation And Processing Of Foods (AREA)
- Cosmetics (AREA)
Abstract
"OLEOSINAS RECOMBINANTES DE CACAU E SEU USO COMO AGENTES AROMATIZANTES E EMULSIFICANTES". A presente invenção refere-se a genes recombinantes codificando para proteínas do tipo oleosina em cacau e a polipeptídios codificados por tais genes. Em particular, a presente invenção refere-se ao uso de tais genes e produtos dos genes para a produção de emulsificantes, agentes encapsulantes e componentes aromatizantes úteis nas indústrias alimentícia, farmacêutica e cosmética.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99122943 | 1999-11-18 | ||
PCT/EP2000/011317 WO2001036648A1 (en) | 1999-11-18 | 2000-11-15 | Recombinant oleosins from cacao and their use as flavoring or emulsifying agents |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0015693A true BR0015693A (pt) | 2002-07-16 |
Family
ID=8239421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0015693-0A BR0015693A (pt) | 1999-11-18 | 2000-11-15 | Oleosinas recombinantes de cacau e seu uso como agentes aromatizantes e emulsificantes |
Country Status (9)
Country | Link |
---|---|
US (1) | US7126042B1 (pt) |
EP (1) | EP1235919B1 (pt) |
AP (1) | AP2002002509A0 (pt) |
AT (1) | ATE270340T1 (pt) |
AU (1) | AU1280601A (pt) |
BR (1) | BR0015693A (pt) |
CA (1) | CA2391399A1 (pt) |
DE (1) | DE60011930T2 (pt) |
WO (1) | WO2001036648A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003088749A1 (en) | 2002-04-18 | 2003-10-30 | Monsanto Technology Llc | Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
FI20040813A (fi) * | 2004-06-14 | 2005-12-15 | Timo Kalevi Korpela | Hydrofobisia molekyylejä stabiloivat proteiinit |
CN101213302B (zh) | 2005-07-01 | 2012-09-05 | 康乃尔研究基金会 | 咖啡油质蛋白基因和启动子 |
US8741337B2 (en) * | 2008-01-04 | 2014-06-03 | Aveka, Inc. | Encapsulation of oxidatively unstable compounds |
US20110020519A1 (en) * | 2008-01-04 | 2011-01-27 | Aveka, Inc. | Encapsulation of oxidatively unstable compounds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK61695A (da) * | 1995-06-01 | 1996-12-02 | Aarhus Oliefabrik As | Kakaoflavouraktive peptider, DNA som koder for dem, fremgangsmåder til fremstilling af peptiderne og deres anvendelse til frembringelse af kakaoflavour |
-
2000
- 2000-11-15 CA CA002391399A patent/CA2391399A1/en not_active Abandoned
- 2000-11-15 AU AU12806/01A patent/AU1280601A/en not_active Abandoned
- 2000-11-15 BR BR0015693-0A patent/BR0015693A/pt not_active Application Discontinuation
- 2000-11-15 AT AT00974542T patent/ATE270340T1/de not_active IP Right Cessation
- 2000-11-15 WO PCT/EP2000/011317 patent/WO2001036648A1/en active Search and Examination
- 2000-11-15 US US10/129,720 patent/US7126042B1/en not_active Expired - Fee Related
- 2000-11-15 DE DE60011930T patent/DE60011930T2/de not_active Expired - Lifetime
- 2000-11-15 AP APAP/P/2002/002509A patent/AP2002002509A0/en unknown
- 2000-11-15 EP EP00974542A patent/EP1235919B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU1280601A (en) | 2001-05-30 |
AP2002002509A0 (en) | 2002-06-30 |
EP1235919A1 (en) | 2002-09-04 |
DE60011930T2 (de) | 2006-05-11 |
US7126042B1 (en) | 2006-10-24 |
ATE270340T1 (de) | 2004-07-15 |
CA2391399A1 (en) | 2001-05-25 |
DE60011930D1 (de) | 2004-08-05 |
EP1235919B1 (en) | 2004-06-30 |
WO2001036648A1 (en) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999033982A3 (en) | Human genes and gene expression products i | |
NZ502392A (en) | Interleukin-18 binding proteins (IL-18BP) their preparation and use in pharmaceuticals | |
DE69334266D1 (de) | Therapeutische Zusammensetzungen aus Antikorper und Antisens Nukleinsäuren gegen Serrate | |
WO1999058675A3 (en) | Human genes and gene expression products v | |
WO1999038972A9 (en) | Human genes and gene expression products ii | |
WO2002022776A3 (en) | Human coagulation factor vii variants | |
ATE381578T1 (de) | Peptide, basierend auf der sequenz des menschlichen lactoferrins und ihre anwendung | |
CY1110128T1 (el) | Καταλυτικα μονοκλωνικα αντισωματα με δραστικοτητα πρωτεασης για την εκλεκτικη λυση του πρωτεϊνικου συστατικου των πλακων και συνονθυλευματων που σχετιζονται με παθολογικες καταστασεις | |
ATE435661T1 (de) | Adjuvant qs-21 enthaltende zusammensetzungen mit polysorbate oder cyclodextrin als hilfsmittel | |
BR0007980A (pt) | Processo para a preparação de derivadosmulti-reticulados de ácido hialurÈnico, hamulti-reticulado, ha reticulado em si próprio,produto, e, uso de ha | |
PT749317E (pt) | Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade | |
WO2002014500A3 (en) | Human genes and gene expression products | |
CY1107470T1 (el) | Συνθεσεις γλυκοσυλιωμενης λεπτινης και σχετικες μεθοδοι | |
WO2001066753A3 (en) | Human genes and gene expression products | |
CY1105008T1 (el) | Αντιμικροβιακη ενεργοτητα του πρωτου κατιονικου συγκροτηματος της ανθρωπινης λακτοφερρινης | |
IL92937A0 (en) | Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it | |
WO2001005825A3 (en) | Nucleic acid sequences encoding putative angiopoietin proteins | |
DE69230135T2 (de) | Dna-sequenz, die für rinder-g(a)-lactalbumin kodiert, und nutzungsmethoden | |
NL300830I1 (nl) | Protein Q, een recombinant chimeer eiwit, bestaande uit vijf antigenefragmenten van vier verschillende Leishmania infantum (zymodeme Mon-1) eiwitten | |
BG104266A (en) | Aminoterminally incised mcp-2 as haemokin antagonists | |
WO2002044320A3 (en) | Human elongase genes and uses thereof | |
BR0015693A (pt) | Oleosinas recombinantes de cacau e seu uso como agentes aromatizantes e emulsificantes | |
WO2002070549A3 (en) | Chimeric polypeptides of serum albumin and uses related thereto | |
DK0966533T3 (da) | Aktivitetsafhængig neurotrof faktor III (ADNF III). | |
WO2000056866A3 (en) | Akt-3 nucleic acids, polypeptides, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Ipc: C12N 15/82 (2006.01), C07K 14/415 (2006.01) |